Revenue $145.00M, up 2.1% on a year earlier. Diluted EPS -$1.97 against -$2.13.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $145.00M | $389.00M | $142.00M | +2.1% |
| Operating income | -$815.00M | -$1.39B | -$907.00M | |
| Net income | -$782.00M | -$1.34B | -$825.00M | |
| Diluted EPS | -$1.97 | -$3.40 | -$2.13 | |
| Operating cash flow | -$526.00M | -$630.00M | -$919.00M | |
| Capital expenditures | -$37.00M | -$62.00M | -$3.00M | |
| Free cash flow | -$563.00M | -$692.00M | -$922.00M |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Moderna (MRNA) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/MRNA/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
